Cargando…
Pretreatment platelet count predicts survival outcome of patients with de novo non-M3 acute myeloid leukemia
BACKGROUND: Pretreatment platelet count has been reported as a potential tool to predict survival outcome in several solid tumors. However, the predictive value of pretreatment platelet count remains obscure in de novo acute myeloid leukemia (AML) excluding acute promyelocytic leukemia (M3). METHODS...
Autores principales: | Zhang, Qianying, Dai, Kanchun, Bi, Laixi, Jiang, Songfu, Han, Yixiang, Yu, Kang, Zhang, Shenghui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5742276/ https://www.ncbi.nlm.nih.gov/pubmed/29302387 http://dx.doi.org/10.7717/peerj.4139 |
Ejemplares similares
-
Neutrophil-to-lymphocyte ratio correlates with prognosis and response to chemotherapy in patients with non-M3 de novo acute myeloid leukemia
por: Zhang, Qianying, et al.
Publicado: (2021) -
The pretreatment albumin to globulin ratio predicts survival in patients with natural killer/T-cell lymphoma
por: Bi, Xi-wen, et al.
Publicado: (2016) -
Reticulated Platelet Count as a Diagnostic Tool in Immune Thrombocytopenia (ITP)
por: Butt, Aqsa Javed, et al.
Publicado: (2023) -
Leukocytapheresis in Chronic Myeloid Leukemia With Leukostasis
por: Raghuwanshi, Babita, et al.
Publicado: (2020) -
A Survival Analysis of Acute Myeloid Leukemia Patients Treated With Intensive Chemotherapy: A Single Center Experience
por: Jimbu, Laura, et al.
Publicado: (2023)